Home » Newsletters » BioWorld Asia

BioWorld Asia

March 1, 2000

View Archived Issues

Oxford GlycoSciences Pushes Proteomics With $52M Funding

Patent On Transgenic Stem Cells Causes Furor In Europe

EU Technical Work Continues Despite Doubts Around Biotech

KS Biomedix Raises $24.5M As It Prepares For Phase III

Antibiotic Use Must Decrease To Remove Resistant Bacteria

Israeli Group Plans Studies Of Cancer Sensitivity Test In China

Strathmann Plans To Develop Therapeutics For HIV, Cancer

EuropaBio Gets Support From Scientists On GM Foods Issue

Euro Commission Takes Neutral Stance On Genetic Technologies

European Pharma Industry Opposes Liability Extensions

Genset Reports Increase Of 50 Percent In Loss For 1999

Other News To Note

Kamada, Red Cross Collaborate On Plasma Therapeutic Product

Appligene Takes Majority Position In Excell Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...